Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

(2009) Mitsue Saito et al.   LANCET ONCOLOGY

Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy

(2009) Eva Ellebæk et al.   Current Opinion in Supportive and Palliative Care

Palonosetron Hydrochloride Is an Effective and Safe Option to Prevent Chemotherapy-induced Nausea and Vomiting in Children

(2008) Ana Carolina Sepúlveda-Vildósola et al.   ARCHIVES OF MEDICAL RESEARCH

Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response

(2008) Elena Massa et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

(2008) Zhaocai Yu et al.   SUPPORTIVE CARE IN CANCER

Antiemetics: an update and the MASCC guidelines applied in clinical practice

(2007) Jørn Herrstedt   Nature clinical practice. Oncology